As the use of artificial intelligence (AI) takes hold in Asia’s healthcare industry, researchers are collecting detailed health profiles of citizens and using the data to test treatments, monitor adverse drug reactions in patients, detect the risk of cognitive issues in children... Read More
Driven by the needs of its growing number of aging adults, the Japanese healthcare industry is rapidly adopting digital technology to bolster the work of physicians, nurses and medical researchers. Increasingly, Japanese doctors are digitizing medical records and consolidating metadata health data... Read More
This article was originally published on MedTech Intelligence. The use of artificial intelligence in healthcare is accelerating rapidly, as devices and products that mimic human learning and behavior are on track to get regulatory approval in the United States, Europe and increasingly,... Read More
This article was originally published on Medtech Intelligence. Artificial intelligence devices or products, known popularly as AI, imitate intelligent behavior or mimic human learning and reasoning. In its more basic forms, artificial intelligence has been used in the healthcare field to perform... Read More
Beginning in September, Japan will enforce recently codified amendments to its Pharmaceutical and Medical Device Act, affecting quality management, device registration, the regulation of medical software and third-party certifications. The new requirements, designed to guard against health problems associated with poorly regulated... Read More
Systematic evaluations of the effects of health technologies in Japan, China, and South Korea conducted over the past three years are showing success in determining the clinical benefits and cost-effectiveness of widely used drugs, adjusting pricing of drugs and medical devices and... Read More
This article was originally published on MedTech Intelligence. Driven by an aging population with growing needs for new medical technologies—and more means to pay for them—governments and hospitals in China, Japan, Singapore, Thailand and Korea are joining forces to purchase an increasing... Read More
One year after Japan tightened its drug pricing system in a bid to make cutting-edge treatments more affordable, the restrictions threaten to slow drug sales to the country, a pharmaceutical industry leader warned last month. Under the new policy, announced in 2018,... Read More
This article was originally published on Medtech Intelligence. Precision medicine, an emerging toolkit of ways to better understand the complex mechanisms underlying a patient’s health, disease, or condition, and to better predict which treatments will be most effective, has grown unevenly outside... Read More
Six months after Collategene became the first gene therapeutic drug cleared for use in Japan, the country’s health insurance system announced in September 2019 it would be placed on the list of pharmaceuticals approved for coverage. The drug, which introduces genes that... Read More